maximum weight loss tirzepatide surmount trials SURMOUNT-1 Trial Tirzepatide vs semaglutide: A new

This finding suggests that GLP-1 receptor agonists may have direct or indirect effects on erectile function beyond what can be explained by metabolic improvements alone

Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials

The PSA and the cost-effectiveness acceptability curves suggested that subcutaneous tirzepatide had a larger potential of being cost-effective when compared with oral semaglutide, with a 97.8% probability at a WTP of $150,000 per QALY at 68 weeks

Semaglutide is a pure GLP-1 receptor agonist: it mimics glucagon-like peptide-1, a hormone your gut releases after eating

Accessing it outside of a clinical trial requires investigational pathways or compounded formulations, which carry different regulatory considerations

However, a lot of prescribers write Ozempic and Mounjaro off-label for weight management too